NNAlign-MA; MHC peptidome deconvolution for accurate MHC binding motif characterization and improved t-cell epitope predictions

Bruno Alvarez, Birkir Reynisson, Carolina Barra, Søren Buus, Nicola Ternette, Tim Connelley, Massimo Andreatta, Morten Nielsen*

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

85 Citations (Scopus)
152 Downloads (Pure)

Abstract

The set of peptides presented on a cell's surface by MHC molecules is known as the immunopeptidome. Current mass spectrometry technologies allow for identification of large peptidomes, and studies have proven these data to be a rich source of information for learning the rules of MHC-mediated antigen presentation. Immunopeptidomes are usually poly-specific, containing multiple sequence motifs matching the MHC molecules expressed in the system under investigation. Motif deconvolution -the process of associating each ligand to its presenting MHC molecule(s)- is therefore a critical and challenging step in the analysis of MS-eluted MHC ligand data. Here, we describe NNAlign-MA, a computational method designed to address this challenge and fully benefit from large, poly-specific data sets of MS-eluted ligands. NNAlign-MA simultaneously performs the tasks of (1) clustering peptides into individual specificities; (2) automatic annotation of each cluster to an MHC molecule; and (3) training of a prediction model covering all MHCs present in the training set. NNAlign-MA was benchmarked on large and diverse data sets, covering class I and class II data. In all cases, the method was demonstrated to outperform state-ofthe- art methods, effectively expanding the coverage of alleles for which accurate predictions can be made, resulting in improved identification of both eluted ligands and T-cell epitopes. Given its high flexibility and ease of use, we expect NNAlign-MA to serve as an effective tool to increase our understanding of the rules of MHC antigen presentation and guide the development of novel T-cellbased therapeutics.

Original languageEnglish
JournalMolecular and Cellular Proteomics
Volume18
Issue number12
Pages (from-to)2459-2477
Number of pages19
ISSN1535-9476
DOIs
Publication statusPublished - 2019

Cite this